GLP-1 receptor agonists and pancreatic cancer
This study provides reassuring data that GLP-1 receptor agonists are not associated with an increased risk of pancreatic cancer.
Register for free access or login.
Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.
Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.
